Peripheral Blood Stem Cell TransplantationTransplantation, AutologousHematopoietic Stem Cell TransplantationHematopoietic Stem Cell MobilizationTransplantation ConditioningTransplantation, HomologousMelphalanGranulocyte Colony-Stimulating FactorLeukapheresisAntigens, CD34Combined Modality TherapyHematologic NeoplasmsBlood Component RemovalStem Cell TransplantationMultiple MyelomaCyclophosphamideLeukocytes, MononuclearAntineoplastic Combined Chemotherapy ProtocolsMyeloablative AgonistsGraft vs Host DiseaseBusulfanTreatment OutcomeLymphoma, Non-HodgkinBone Marrow TransplantationGraft SurvivalHematopoietic Stem CellsEtoposideThiotepaAntineoplastic Agents, AlkylatingRemission InductionRecurrenceCytophagocytosisCarmustineIfosfamideSalvage TherapyVincristineAmyloidosisStem CellsHematopoiesisCytarabineHodgkin DiseaseCord Blood Stem Cell TransplantationDisease-Free SurvivalTransplantation ChimeraNeoplasmsRetrospective StudiesTissue DonorsTime FactorsSurvival RateWhole-Body IrradiationInfectionLymphoma, T-CellSurvival AnalysisDoxorubicinHistocompatibilityPlatelet CountT-LymphocytesPOEMS SyndromeRecombinant ProteinsImmunosuppressive AgentsHistocompatibility TestingBlood CellsPrednisoneCarboplatinLeukemia, Myeloid, AcuteDexamethasoneBlood Cell CountTransplantation, IsogeneicLeukemiaVidarabineFollow-Up StudiesCells, CulturedAntineoplastic AgentsFlow CytometryLymphomaImmunophenotypingCytomegalovirus InfectionsProspective StudiesBone Marrow PurgingAntigens, CDFatal OutcomeGraft vs Leukemia EffectLymphocytesFeasibility StudiesLymphocyte ActivationHLA AntigensAnemia, AplasticCell SeparationMyelodysplastic SyndromesLymphocyte DepletionBone MarrowLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLiver TransplantationBlood Transfusion, AutologousBlood DonorsLeukocyte CountMonocytesImmunosuppressionCyclosporinePrognosis